Ras an up date.
-
Upload
suneth-weerarathna -
Category
Health & Medicine
-
view
135 -
download
1
Transcript of Ras an up date.
![Page 1: Ras an up date.](https://reader030.fdocuments.net/reader030/viewer/2022032700/55d53e6bbb61ebae088b45a9/html5/thumbnails/1.jpg)
RENAL ARTERY STENOSIS-An Update-
DR.W.A.P.S.R.WEERARATHNAREGISTRAR-WD 10/02
![Page 2: Ras an up date.](https://reader030.fdocuments.net/reader030/viewer/2022032700/55d53e6bbb61ebae088b45a9/html5/thumbnails/2.jpg)
Objectives
Renal artery Stenosis(RAS) –an overview RAS & Renovascular hypertension-
Pathophysiology Clinical presentation Evaluation & diagnostic modalities Current clinical evidence Management options- current
reccomendations Summary References
![Page 3: Ras an up date.](https://reader030.fdocuments.net/reader030/viewer/2022032700/55d53e6bbb61ebae088b45a9/html5/thumbnails/3.jpg)
RAS-an overveiw
Mainly 2 types- 1. Atherosclotic reno vascular
disease(ARVD) 2.Fibromuscular dysplasia (FMD)
<10% Two common clininical syndromes- 1. Hypertension 2. Ischaemic nephropathty
![Page 4: Ras an up date.](https://reader030.fdocuments.net/reader030/viewer/2022032700/55d53e6bbb61ebae088b45a9/html5/thumbnails/4.jpg)
FMD Affects media in >90% Cause-unknown ?genetic/?smoking/?hormonal/?disorders
of vasa vasarum Female>male, common in 15-50 years Common in distal 2/3 of renal
artey/branches Angiography-beading/aneursyms Progressive dissection/thrombosis
common in intimal & periaoric types
![Page 5: Ras an up date.](https://reader030.fdocuments.net/reader030/viewer/2022032700/55d53e6bbb61ebae088b45a9/html5/thumbnails/5.jpg)
ARVD 90% Usually osteal/proximal 1/3 of main renal
artery/perirenal aorta Ischaemic
nephropathy-segmental/diffuse Increased prevalence- advanced
age/DM/aoroto-iliac disease/CAD/HTN ARVD-5 years after diagnosis progressive stenosis 51% total occlusion 3-16% renal atrophy 21%
(60% occlusion)
![Page 6: Ras an up date.](https://reader030.fdocuments.net/reader030/viewer/2022032700/55d53e6bbb61ebae088b45a9/html5/thumbnails/6.jpg)
RAS pathophysiology-Interrelation among Renal-Artery Stenosis, Hypertension, and Chronic Renal Failure.
Safian RD, Textor SC. N Engl J Med 2001;344:431-442.
![Page 7: Ras an up date.](https://reader030.fdocuments.net/reader030/viewer/2022032700/55d53e6bbb61ebae088b45a9/html5/thumbnails/7.jpg)
RAS & Renovascular hypertension
![Page 8: Ras an up date.](https://reader030.fdocuments.net/reader030/viewer/2022032700/55d53e6bbb61ebae088b45a9/html5/thumbnails/8.jpg)
![Page 9: Ras an up date.](https://reader030.fdocuments.net/reader030/viewer/2022032700/55d53e6bbb61ebae088b45a9/html5/thumbnails/9.jpg)
Renovascular HTN-accelarated/malignant NOT readily distinguishable from
Essential HTN Classic features- (none have
significant predictive value!) Hypokalemia Abdominal bruit Absence of family H/O HTN Duration of HTN < 1 year Onset of HTN < 50 years
![Page 10: Ras an up date.](https://reader030.fdocuments.net/reader030/viewer/2022032700/55d53e6bbb61ebae088b45a9/html5/thumbnails/10.jpg)
Majority of Renovascular HTN have Essential HTN
HTN usually persist despite revascurization!
Reverse tachyphylaxis- sustained HTN redused plasma Renin levels (limitations in measuring plasma renin levels in patients with Renovascular HTN)
![Page 11: Ras an up date.](https://reader030.fdocuments.net/reader030/viewer/2022032700/55d53e6bbb61ebae088b45a9/html5/thumbnails/11.jpg)
Progressive Atherosclerosis, Renal-Artery Stenosis, and Ischemic Nephropathy.
Safian RD, Textor SC. N Engl J Med 2001;344:431-442.
![Page 12: Ras an up date.](https://reader030.fdocuments.net/reader030/viewer/2022032700/55d53e6bbb61ebae088b45a9/html5/thumbnails/12.jpg)
RAS-Pathology/Histology
![Page 13: Ras an up date.](https://reader030.fdocuments.net/reader030/viewer/2022032700/55d53e6bbb61ebae088b45a9/html5/thumbnails/13.jpg)
Angiographic Appearance of the Two Most Common Forms of Renal-Artery Stenosis.
Safian RD, Textor SC. N Engl J Med 2001;344:431-442.
![Page 14: Ras an up date.](https://reader030.fdocuments.net/reader030/viewer/2022032700/55d53e6bbb61ebae088b45a9/html5/thumbnails/14.jpg)
Narrowing of an accessary renal artey…..
![Page 15: Ras an up date.](https://reader030.fdocuments.net/reader030/viewer/2022032700/55d53e6bbb61ebae088b45a9/html5/thumbnails/15.jpg)
Clinical Findings Associated with Renal-Artery Stenosis.
Safian RD, Textor SC. N Engl J Med 2001;344:431-442.
![Page 16: Ras an up date.](https://reader030.fdocuments.net/reader030/viewer/2022032700/55d53e6bbb61ebae088b45a9/html5/thumbnails/16.jpg)
Evaluation of RAS
Noninvasive/ invasive modalities May include studies to asses Overall RFT Asses RAAS Perfusion studies-differential
renal BF Imaging studies- to asses RAS
![Page 17: Ras an up date.](https://reader030.fdocuments.net/reader030/viewer/2022032700/55d53e6bbb61ebae088b45a9/html5/thumbnails/17.jpg)
Noninvasive modalitise
Measuring the response of RAAS-more useful in younger patients with FMD(HTN is renin dependent than in elderly with ARVD! & likely to be cured by revascularization!)
Renin –Na+ profiling Assesment of (Renin) before / after
captopril Assesment of effect of BP/RFT of an ACEI Captopril renography-diffential renal
perfusion cont…
![Page 18: Ras an up date.](https://reader030.fdocuments.net/reader030/viewer/2022032700/55d53e6bbb61ebae088b45a9/html5/thumbnails/18.jpg)
Elderly with ARVDimaging is prefferd!
Duplex ultrasonography-assesment of Renal arteries/BF velosities/pressure wave forms
MRA- Gd enhanced Renal arteries/aorta
CTA- (Gd usually not toxic/exclude if eGFR
<30 )
![Page 19: Ras an up date.](https://reader030.fdocuments.net/reader030/viewer/2022032700/55d53e6bbb61ebae088b45a9/html5/thumbnails/19.jpg)
Invasive modalities
Contrast enhanced angiography- To confirm the diagnosis To detect cause of RAS To evaluate the extent of intrarenal
vascular disease To determine the dimentions To identify associate
aneurysms/occlusive disease of aorta Intraarterial DSA- low volume of contrast
medium needed & no worsening of RFT.
![Page 20: Ras an up date.](https://reader030.fdocuments.net/reader030/viewer/2022032700/55d53e6bbb61ebae088b45a9/html5/thumbnails/20.jpg)
Noninvasive Assessment of Renal-Artery Stenosis.
Safian RD, Textor SC. N Engl J Med 2001;344:431-442.
![Page 21: Ras an up date.](https://reader030.fdocuments.net/reader030/viewer/2022032700/55d53e6bbb61ebae088b45a9/html5/thumbnails/21.jpg)
Algorithm for Evaluating Patients in Whom Renal-Artery Stenosis Is Suspected.
Safian RD, Textor SC. N Engl J Med 2001;344:431-442.
![Page 22: Ras an up date.](https://reader030.fdocuments.net/reader030/viewer/2022032700/55d53e6bbb61ebae088b45a9/html5/thumbnails/22.jpg)
Mangement-ACCF/AHA Guidelines publishedin 2013/March
![Page 23: Ras an up date.](https://reader030.fdocuments.net/reader030/viewer/2022032700/55d53e6bbb61ebae088b45a9/html5/thumbnails/23.jpg)
Medical treatment-class 1 ACE inhibitors are effective medications
for treatment of hypertension associated with unilateral RAS. (Levelof Evidence: A)
Angiotensin receptor blockers are effective medications for treatment of hypertension associated with unilateral RAS. (Level of Evidence: B)
Calcium-channel blockers are effective medicationsfor treatment of hypertension associated with unilateral RAS. (Level of Evidence: A)
![Page 24: Ras an up date.](https://reader030.fdocuments.net/reader030/viewer/2022032700/55d53e6bbb61ebae088b45a9/html5/thumbnails/24.jpg)
Beta blockers are effective medications for treatment of hypertension associated with RAS. (Level of Evidence: A)
![Page 25: Ras an up date.](https://reader030.fdocuments.net/reader030/viewer/2022032700/55d53e6bbb61ebae088b45a9/html5/thumbnails/25.jpg)
Indications for revascularization-
Asymptomatic stenosis -class 2 B Percutaneous revascularization may be
considered for treatment of an asymptomatic bilateral or solitary viable kidney with a hemodynamically significant RAS. (Level of Evidence: C)
The usefulness of percutaneous revascularization of an asymptomatic unilateral hemodynamically significant RAS in a viable kidney is not well established and is presently clinically unproven. (Level of Evidence: C)
![Page 26: Ras an up date.](https://reader030.fdocuments.net/reader030/viewer/2022032700/55d53e6bbb61ebae088b45a9/html5/thumbnails/26.jpg)
Hypertension-class 2a Percutaneous revascularization is
reasonable for patients with- Hemodynamically significant RAS and accelerated hypertension, Resistant hypertension, Malignant hypertension,
Hypertension with an unexplained unilateral small kidney
Hypertension with intolerance to medication
![Page 27: Ras an up date.](https://reader030.fdocuments.net/reader030/viewer/2022032700/55d53e6bbb61ebae088b45a9/html5/thumbnails/27.jpg)
Preservation of renal functions
Class 2A Percutaneous revascularization is
reasonable for patients with RAS and progressive chronic kidney disease with bilateral RAS or a RAS to a solitary functioning kidney. (Level of Evidence: B)
Class2 B Percutaneous revascularization may be
considered for patients with RAS and chronic renal insufficiency with unilateral RAS. (Level of Evidence: C)
![Page 28: Ras an up date.](https://reader030.fdocuments.net/reader030/viewer/2022032700/55d53e6bbb61ebae088b45a9/html5/thumbnails/28.jpg)
Endovascular treatment for RAS
Class1 Renal stent placement is indicated
for ostia atherosclerotic RAS lesions that meet the clinical criteria for intervention. (Level of Evidence: B)
Balloon angioplasty with bailout stent placement if necessary is recommended for fibromuscular dysplasia lesions. (Level of Evidence: B)
![Page 29: Ras an up date.](https://reader030.fdocuments.net/reader030/viewer/2022032700/55d53e6bbb61ebae088b45a9/html5/thumbnails/29.jpg)
Endovascular stenting in RAS
![Page 30: Ras an up date.](https://reader030.fdocuments.net/reader030/viewer/2022032700/55d53e6bbb61ebae088b45a9/html5/thumbnails/30.jpg)
![Page 31: Ras an up date.](https://reader030.fdocuments.net/reader030/viewer/2022032700/55d53e6bbb61ebae088b45a9/html5/thumbnails/31.jpg)
Impact of RAS on CCF& UA Class 1 Percutaneous revascularization is indicated for
patients with hemodynamically significant RAS and recurrent, unexplained congestive heart failure or sudden, unexplained pulmonary edema-Flash pulmonary oedema. (Level of Evidence: B)
Class 2A Percutaneous revascularization is reasonable
for patients with hemodynamically significant RAS and unstable angina. (Level of Evidence: B)
![Page 32: Ras an up date.](https://reader030.fdocuments.net/reader030/viewer/2022032700/55d53e6bbb61ebae088b45a9/html5/thumbnails/32.jpg)
Surgery for RAS
Class1 Vascular surgical reconstruction is
indicated for patients with fibromuscular dysplastic RAS with clinical indications for interventions (same as for percutaneous transluminal angioplasty), especially those exhibiting complex disease that extends into the segmental arteries and those having macroaneurysms. (Level of
![Page 33: Ras an up date.](https://reader030.fdocuments.net/reader030/viewer/2022032700/55d53e6bbb61ebae088b45a9/html5/thumbnails/33.jpg)
Vascular surgical reconstruction is indicated for patients with atherosclerotic RAS and clinical indications for intervention, especially those with multiple small renal arteries or early primary branching of the main renal artery. (Level of Evidence: B)
![Page 34: Ras an up date.](https://reader030.fdocuments.net/reader030/viewer/2022032700/55d53e6bbb61ebae088b45a9/html5/thumbnails/34.jpg)
Vascular surgical reconstruction is indicated for patients with atherosclerotic RAS in combination with pararenal aortic reconstructions (in treatment of aortic aneurysms or severe aortoiliac occlusive disease).
![Page 35: Ras an up date.](https://reader030.fdocuments.net/reader030/viewer/2022032700/55d53e6bbb61ebae088b45a9/html5/thumbnails/35.jpg)
Refferences..
ACCF/AHA Practice guide line-Management of patients with Peripheral atrerial Diseases(compilation of 2005 &2011 ACCF/AHA guide line reccomendations)
NEJM-Renal-Artery Stenosis- Robert D Saflan & Stephan C Textor MD NEJ MED 2001
![Page 36: Ras an up date.](https://reader030.fdocuments.net/reader030/viewer/2022032700/55d53e6bbb61ebae088b45a9/html5/thumbnails/36.jpg)